Wildcat Capital Management

Latest statistics and disclosures from Wildcat Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ULCC, RLX, ALLO, TTAN, GTLB, and represent 100.00% of Wildcat Capital Management's stock portfolio.
  • Added to shares of these 2 stocks: TTAN, GTLB.
  • Started 2 new stock positions in GTLB, TTAN.
  • Reduced shares in these 4 stocks: RLX (-$31M), TIC (-$17M), URGN (-$6.8M), Silexion Therapeutics Corp.
  • Sold out of its positions in TIC, Silexion Therapeutics Corp, URGN.
  • Wildcat Capital Management was a net seller of stock by $-53M.
  • Wildcat Capital Management has $145M in assets under management (AUM), dropping by -13.80%.
  • Central Index Key (CIK): 0001582384

Tip: Access up to 7 years of quarterly data

Positions held by Wildcat Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Wildcat Capital Management

Wildcat Capital Management holds 5 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Frontier Group Hldgs (ULCC) 85.4 $124M 28M 4.42
 View chart
Rlx Technology Sponsored Ads (RLX) 11.6 $17M -64% 6.4M 2.63
 View chart
Allogene Therapeutics (ALLO) 2.5 $3.6M 2.9M 1.24
 View chart
Servicetitan Shs Cl A (TTAN) 0.3 $417k NEW 4.1k 100.83
 View chart
Gitlab Class A Com (GTLB) 0.2 $264k NEW 5.9k 45.08
 View chart

Past Filings by Wildcat Capital Management

SEC 13F filings are viewable for Wildcat Capital Management going back to 2014

View all past filings